The Bone Metabolism Characteristics of Premature Ovarian Insufficiency

Launched by SHI YUN · Mar 25, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how premature ovarian insufficiency (POI), a condition where the ovaries stop functioning properly before age 40, affects bone health. Researchers want to understand how this condition influences bone metabolism and bone mineral density, which is important for maintaining strong bones and preventing diseases like osteoporosis.

Women between the ages of 18 and 39 who have been diagnosed with POI may be eligible to participate. To join, they would need to agree to participate and sign a consent form. Participants will undergo various assessments to help researchers learn more about how POI impacts bone health. It's important to note that women who are pregnant, breastfeeding, or have certain serious health conditions will not be eligible for this trial. This study aims to gather valuable information that could lead to better care and treatment options for women with POI.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Patients diagnosed by Western medicine with premature ovarian insufficiency. 18 ≤ patients' age ≤ 39 years;. Patients who voluntarily participate in this study, sign an informed consent form.
• Exclusion Criteria:
• • Patients with congenital gonadal dysplasia or a family history similar to "early menopause".
• • POI patients with acquired organic lesions or ovarian surgery. Patients who have taken Western or herbal medicine artificial cycle therapy or other endocrine therapy in the past three months.
• • Patients with serious primary diseases and mental disorders such as cardiovascular and cerebrovascular, liver, kidney and hematopoietic system.
• • Patients who are breastfeeding or pregnant.